Are You Planning to Visit Outer Space? Do You Know It Could Cause Severe Bone and Muscle Loss and Even Brain Damage?
Optimize Blood Circulation for Significant Outcomes!
Human spaceflight has been a predominantly government-funded activity, but now commercial flights are becoming a reality. According to various estimates, the space tourism industry will grow to $1 billion by the year 2021. However, expert consesus reveals the two biggest challanges facing industry growth are the high risks associated with environmental hazards and mechanical failures.
Environmental hazards far outweigh mechanical ones. Medical issues eminating from a microgravity environment even during short flights such as possible blindness, significant bone density and muscle mass loss, brain and cardiovascular damage, and immune system deterioration are the most recorded in space biomedical research by the National Aeronautical Space Agency (NASA), the former Russian Federal Space Agency, and the European Space Agency (ESA).
A NASA-supported study released on December 31, 2012 reported that spaceflight could adversly affect astronauts and speed up the onset of Alzheimer's disease. In addition, diminishing bone mass triggers an increase in blood calcium levels, which elevates the risk of kidney stones.
According to the Bone Vascular and Microcirculation Laboratory at the University of Texas Arlington, "Recent evidence suggests a link between cardiovascular disease and osteoporosis. In addition, the vascular supply is critical for proper bone healing following fracture and bone blood vessels participate in a variety of physiological processes in the bone marrow."
Various drugs have been tried to counter the detrimental effects of spaceflight such as hormone therapy (e.g., estrogen, progestin), bisphosphonates, and teriparatide. However, no significant data has been published about their efficacy in countering the bone damage associated with spaceflight.
D'OXYVA® (deoxyhemoglobin vasodilator) is a novel, clinically validated, non-opioid and side effect-free bone microcirculatory solution and is the must-have complete health technology in every household.
In various clinical trials, D'OXYVA has shown extraordinary results in improving cardiovascular and microvascular health through significantly improving blood circulation in many parts of the body. D'OXYVA's affects are especially profound on the functionality of microvessels that web the entire body and reach every single cell and tissue in nearly every organ.
Bone density and brain functions are highly dependent on proper microcirculation and D'OXYVA's role in helping space tourism could be significant. D'OXYVA has validated leading independent research results and demonstrated above-average results in improving a host of physiological functions at the same time.
Taking D'OXYVA daily, users have reported a number of significant quality of life benefits besides significantly reducing the risks of mild to severe chronic conditions, including but not limited to:
Significantly increased cardiac function, physical fitness, endurance and strength, muscle size, body tone, faster recovery from sports injuries and surgical trauma
Improved self-esteem via promoting healthy and radiant skin, complexion, dry skin relief, and acne reduction
Significant reduction in downtime from other skin treatments and cosmetic procedures when used in combination, reduction in the appearance of scars, cellulite, fat, spider veins and stretch marks
Promoting and maintaining a healthy weight, improving general mobility, deeper, more restful sleep
Significant improvement of mental acuity; concentration, problem solving, multitasking, eye-hand coordination, heightened stamina, energy, and focus while managing stress
Improved vitals across the board during checkups with zero adverse event reports after years of regular use by people with various health, demographic, and ethnic backgrounds
Relief from symptoms of microvascular complications
Back to Top ^
What it does
D'OXYVA® (deoxyhemoglobin vasodilator) is the only fully non-invasive, non-irritating, non-opioid, and completely painless, transdermal (over the skin) microcirculatory solution with industry-leading clinical research results that does not break the skin's barrier.
In short, based on current leading neurology, immunology, microvascular, and cellular oxygenation science, D'OXYVA is leading the field by quickly targeting to:
Significantly lower the risk of diabetes and cardiovascular complications
Provide complete healing of difficult wounds together with major pain relief and improved quality of life:
- Detoxify the skin and body
- Improve sleep
- Stamina and skin health
- Reduce inflammation
- And much more for all kinds of people
"I am seeing an increase in muscle mass due to the D'OXYVA. I feel great. Thanks, Dr. Jim" - Dr. Jim Bledsoe from Pensacola, FL United States
"I have found that after only two weeks of using the D'OXYVA system daily that my metabolism has increased and is helping me to lose weight. My sex drive has increased and I am sleeping better throughout the night." - Judy Trocha from Pollock Pines, CA United States
How it works
D'OXYVA's soft vapor solution with FDA-cleared medical CO2 readily dissolves in a molecular form in the skin to increase skin perfusion pressure, microcirculation.
It is non-electrical, handheld, painless, fast, and easy to use with no adverse side effects, according to years of user feedback and the results of past clinical trials with D'OXYVA.
It is an affordable, stand alone and adjunct application locally and all over the body. Taking D'OXYVA is easy; hold it against your skin surface for 5 minutes total, like comfortably inserting your thumb or anywhere you are hurt.
Increased oxygen-rich microcirculatory tissue perfusion is widely reported in published clinical research to improve physiological processes including but not limited to wound, tissue healing and repair, athletic performance, stamina, sleep quality, skin health, and much more.
D'OXYVA has recorded instant, outsized, and sustained improvements of the autonomic nervous system (ANS) in the brain leading to major tissue perfusion, blood circulation in macro-, and microcirculation enhancement in controlled human clinical trials (Phase I to III). These benefits result in significant improvements of essential physiological processes and clinical outcomes.
Medical CO2 gas is a widely accepted so-called gasotransmitter acting as a natural vasodilator amongst other beneficial critical signaling funtions when delivered by D'OXYVA's patented and patent-pending process.
D'OXYVA delivers the highest possible concentration of CO2 and has been clinically studied to significantly increase lasting blood flow volume in the microcirculatory system.
In addition, increased microcirculation with CO2 is widely known to increase the perfusion of oxygen.
Shop All Products
Talk to a Representative
Back to Top ^